"This isn't about you," Rep. Alexandria Ocasio-Cortez (D-NY) told Gilead CEO Daniel O'Day. "We have legislated a system that allows [this] to happen."
Activists say this relatively small giveaway won't advance PrEP access or help end HIV in the U.S. the way a true price reduction would.
Housing and displacement are a major focus of their campaign.
An alliance of advocacy groups called The Partnership rallies Congress for funding while rejecting most Trump administration policies impacting the HIV community.
Five years after Andrew Cuomo announced his plan to end New York state's HIV epidemic by 2020, the governor is shutting off funds to vital HIV prevention and public health programs in New York City.
Activists and doctors say they're ready to go further if Gilead won't agree to -- or the U.S. government won't force -- a price reduction to make PrEP accessible to more Americans who need it.
The #PrEP4All campaign made the call for affordable pre-exposure prophylaxis a national news story.
Given its anti-transgender policies and the lack of resources for trans health and survival, the administration may not be on track to end HIV by 2030.
But a survey reveals that about a third of black and Latino gay men would be willing to pay more than $50 per month for a prescription.
We answer some key questions about the latest new effort to kill the Affordable Care Act, including what it means for people living with HIV and what can do to make a difference.